The use of in vitro lymphocyte responsiveness to specific mitogenic agents in the immunological monitoring of human renal allograft recipients.
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000187:drug effects / Q000494:pharmacology; D002648:Child; D003864:Depression, Chemical; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D066298:In Vitro Techniques; D016030:Kidney Transplantation; D037102:Lectins / Q000494:pharmacology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D008934:Mitogens; D011239:Prednisolone / Q000494:pharmacology / Q000627:therapeutic use; D013268:Stimulation, Chemical; D013299:Streptodornase and Streptokinase / Q000494:pharmacology; D013301:Streptolysins / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D037102:Lectins; D008934:Mitogens; D013301:Streptolysins; D014316:Tritium; D011239:Prednisolone; D013299:Streptodornase and Streptokinase; D001379:Azathioprine; D013936:Thymidine; D014529:Uridine